Sep 28, 2021 / 05:20PM GMT
Charles Cliff Duncan - Cantor Fitzgerald & Co., Research Division - Senior Analyst
Hello. Welcome to the Cantor Global Healthcare Conference for 2021. My name is Charles Duncan. I'm a Managing Director and Senior Biotechnology Analyst with the firm's equity research department. And this is day 2 of the annual event. And I have to say, what a year it has been since we last hosted clients at the 2020 Cantor conference, a year ago or so. It's a pleasure to introduce the next presenting speaker that is -- or the company is called Halozyme. And the speaker is Elaine Sun. Elaine is the company's CFO. Hi, Elaine, good to see you.
Elaine D. Sun - Halozyme Therapeutics, Inc. - Senior VP & CFO
Hi, Charles, so nice to be with you today.
Questions and Answers:
Charles Cliff Duncan - Cantor Fitzgerald & Co., Research Division - Senior AnalystNice to be with you as well. I'm interested to hear a lot about Halozyme, very fresh business, very differentiated. We cover it and enthusiastically so. But before we talk